Jim Werngren

The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

Paolo Miotto, Claudio U. Köser, Philip W. Fowler et al. · The Lancet Microbe · 2022 · 300 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study

Paolo Miotto, Andrea Maurizio Cabibbe, Silke Feuerriegel et al. · mBio · 2014 · 152 citations · Full text

Life Sciences, Genetics, Microbiology +17

Pyrazinamide Resistance and <i>pncA</i> Gene Mutations in <i>Mycobacterium tuberculosis</i>

Pontus Juréen, Jim Werngren, Juan-Carlos Toro et al. · Antimicrobial Agents and Chemotherapy · 2008 · 146 citations · Full text

Life Sciences, Microbiology, Molecular Genetics +16

Drug-Susceptible <i>Mycobacterium tuberculosis</i> Beijing Genotype Does Not Develop Mutation-Conferred Resistance to Rifampin at an Elevated Rate

Jim Werngren, Sven Hoffner · Journal of Clinical Microbiology · 2003 · 129 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis

Thomas Schön, Pontus Juréen, Christian G. Giske et al. · Journal of Antimicrobial Chemotherapy · 2009 · 113 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14